Search results :

Dolutegravir

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2
Hyperglycaemia Hyperglycaemia 12% x
Alanine aminotransferase increased Alanine aminotransferase increased 8% x
Headache Headache 1% - 14% x x
Insomnia Insomnia 1% - 3% x x
Nausea Nausea 1% - 15% x x
Diarrhoea Diarrhoea 1% - 16% x x
Dizziness Dizziness 1% - 5% x x
Dermatitis Rash 0% - 6% x x
Rash Rash 0% - 6% x x
Abnormal dreams Abnormal dreams 1% - 2% x x
Vertigo Vertigo 0% - 2% x
Abdominal pain Abdominal pain x x
Gastrointestinal pain Abdominal pain x x
Autoimmune disorder Autoimmune disorder x
Mental disorder Mental disorder x
Drug eruption Drug eruption x
Asthenia Fatigue x x
Fatigue Fatigue x x
Flatulence Flatulence x x
Gastrointestinal disorder Gastrointestinal disorder x x
Basedow's disease Basedow's disease x
Hepatitis Hepatitis x x
Hepatitis C Hepatitis C x
Hypersensitivity Hypersensitivity x x
Immune system disorder Immune system disorder x
Inflammation Inflammation x
Musculoskeletal disorder Musculoskeletal disorder x
Myositis Myositis x
Nervous system disorder Nervous system disorder x
Neutropenia Neutropenia x
Opportunistic infection Opportunistic infection x
Prurigo Prurigo x
Pruritus Pruritus x x
Urethral disorder Urinary tract disorder x
Urinary tract disorder Urinary tract disorder x
Vomiting Vomiting x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x
Rash macular Rash macular x
Abdominal discomfort Abdominal discomfort x x
Abdominal pain upper Abdominal pain upper x x
Hepatobiliary disease Hepatobiliary disease x x
Rash maculo-papular Rash maculo-papular x
Rash generalised Rash generalised x
Blood creatinine increased Serum creatinine increased x x
Blood bilirubin increased Bilirubin total increased x
Fat redistribution Fat redistribution x
Renal failure Renal impairment x
Renal impairment Renal impairment x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

dolutegravir / dolutegravir

Side effects:27
Source:EMA

DOLUTEGRAVIR

Side effects:36
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label